FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to cardiology and pulmonology, and can be used to determine the severity of the condition of patients with idiopathic and chronic thromboembolic pulmonary hypertension (IPH and CTEPH). An echocardiographic examination is performed to determine systolic pressure in the pulmonary artery (PASP) by formula: PASP = mGDsTV + Pra, where mGDsTV is the maximum systolic gradient on the tricuspid valve, Pra is pressure in right atrium. Diastolic pressure in the pulmonary artery (PADP) is determined by formula: PADP=(3×avDPA-PASP)/2, where avDPA = avGDsTV + Pra, where avGDsTV is the average systolic gradient on the tricuspid valve; pulse pressure (ΔP) in pulmonary artery, systolic volume (SV) is calculated by formula: SV=πr2×VTI, where r is radius of right ventricular outlet tract, VTI is integral of linear velocity of blood flow in right ventricular outlet tract; integral stiffness: ΔP/SV; maximum (Dmax) and minimum (Dmin) internal diameters of the pulmonary artery without considering its walls. Measurements are made on the internal diameter of the pulmonary artery without considering its walls, calculating ΔD = Dmax-Dmin. Then calculated by the formulas: pulmonary artery deformation values: (ΔD/Dmin)×100 %, elasticity factor of pulmonary artery: ΔD/(Dmin×ΔP), integral elasticity of the pulmonary artery: SV/ΔP, stiffness index β of the pulmonary artery: ln(PASP/PADP)/(ΔD/Dmin), Peterson stiffness modulus of the pulmonary artery: (Dmin×ΔP)/ΔD, and the pulmonary artery deformation values in the patients: with IPH≤5.8 %, with CTEPH≤6.7 %; coefficient of extensibility of pulmonary artery: at IPH≤0.8×10-5 Pa-1, at CTEPH≤1.0×10-5 Pa-1; of the integral elongation of the pulmonary artery: with IPH≤0.9 ml/mm Hg, with CTEPH≤1.1 ml/mm Hg; hardness index β of pulmonary artery: at IPH>18.3, with CTEPH>13.8; Peterson stiffness modulus of the pulmonary artery: at IPH>1.3×105 Pa, with CTEPH>1.0×105 Pa; integral stiffness of PA: at IPH>1.1 mm Hg/ml, with CTEPH>0.8 mm Hg/ml, patient's condition is evaluated as severe, which corresponds to III-IV functional class.
EFFECT: method enables the accurate and effective assessment of the severity of the patients with IPH CTEPH.
1 cl, 5 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING THE EFFECTIVENESS OF PROLONGED SPECIFIC THERAPY IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION AND INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION | 2020 |
|
RU2729033C1 |
METHOD OF EVALUATING THE EFFECTIVENESS OF BALLOON ANGIOPLASTY OF PULMONARY ARTERY BRANCHES IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION | 2022 |
|
RU2804340C1 |
METHOD FOR COMPLETE CIRCULAR CRYODENERVATION OF PULMONARY ARTERIES AND PULMONARY TRUNK | 2020 |
|
RU2738568C1 |
METHOD FOR DIAGNOSTICS OF LATENT CARDIAC DECOMPENSATION IN CASE OF CHRONIC PULMONARY HEART | 1993 |
|
RU2071727C1 |
METHOD OF SELECTING THE DIAMETER OF INTERATRIAL COMMUNICATION DURING ATRIOSEPTHOSTOMY IN PATIENTS WITH PULMONARY HYPERTENSION | 2020 |
|
RU2731907C1 |
METHOD OF DIFFERENTIAL DIAGNOSTIC OF ACUTE PULMONARY THROMBOEMBOLISM AND CHRONIC POSTEMBOLIC PULMONARY HYPERTENSION | 2014 |
|
RU2545927C1 |
DIAGNOSTIC TECHNIQUE FOR EARLY SIGNS OF RENAL HEMODYNAMICS DEFICIENCY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE COMPLICATED BY CHRONIC PULMONARY HEART DISEASE | 2019 |
|
RU2723749C1 |
DIAGNOSTIC TECHNIQUE FOR DEGREE OF CARDIAC CHAMBER DYSFUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2014 |
|
RU2561289C1 |
METHOD OF DIAGNOSING DIASTOLIC DYSFUNCTION OF RIGHT VENTRICLE IN PATIENTS WITH CHRONIC PULMONARY HEART | 2012 |
|
RU2495625C1 |
METHOD FOR DETERMINING THROMBOSIS OF LEFT ATRIAL APPENDAGE ACCORDING TO CONTRAST TRANSTHORACIC ECHOCARDIOGRAPHY | 2019 |
|
RU2723391C1 |
Authors
Dates
2020-06-10—Published
2019-10-04—Filed